Literature DB >> 18054868

Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.

Hormuzd A Katki1, Mitchell H Gail1, Mark H Greene2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18054868     DOI： 10.1016/S1470-2045(07)70348-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.

Authors:  Larissa A Korde; Christine M Mueller; Jennifer T Loud; Jeffery P Struewing; Kathy Nichols; Mark H Greene; Phuong L Mai
Journal:  Breast Cancer Res Treat       Date:  2010-05-11       Impact factor: 4.872

2.  Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks.

Authors:  Hormuzd A Katki; Mark H Greene; Maria Isabel Achatz
Journal:  J Natl Cancer Inst       Date:  2018-08-01       Impact factor: 13.506

3.  Evidence that BRCA1- or BRCA2-associated cancers are not inevitable.

Authors:  Bess Levin; Denise Lech; Bernard Friedenson
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

4.  Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec.

Authors:  Michel Dorval; Catherine Noguès; Pascaline Berthet; Jocelyne Chiquette; Marion Gauthier-Villars; Christine Lasset; Claude Picard; Marie Plante; Jacques Simard; Claire Julian-Reynier
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

5.  BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.

Authors:  Alexis D Bakos; Sadie P Hutson; Jennifer T Loud; June A Peters; Ruthann M Giusti; Mark H Greene
Journal:  Health Expect       Date:  2008-09       Impact factor: 3.377

6.  Musings on genome medicine: the value of family history.

Authors:  Angus John Clarke
Journal:  Genome Med       Date:  2009-08-03       Impact factor: 11.117

7.  No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families.

Authors:  S Guedaoura; S Pelletier; W D Foulkes; P Hamet; J Simard; N Wong; Z El Haffaf; J Chiquette; M Dorval
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.